IEPE Unimed Sorocaba

Sorocaba, São Paulo 18060-105

2 studies enrolling now · 2 studies all time

What they study most

Advanced Breast Cancer, Advanced Lung Cancer, HER2 Mutation-Related Tumors, HER2-positive Advanced Breast Cancer, HER2-positive Metastatic Breast Cancer, HR-positive, HER2-negative Advanced Breast Cancer, KRAS Mutant Metastatic Colorectal Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic HER2-positive Breast Cancer, Metastatic Lung Cancer, Solid Tumor, Adult

Studies at this site

• Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors — Recruiting now
• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now